Evogene's Q3 Revenues, Loss Rise | GenomeWeb
NEW YORK (GenomeWeb News) – Evogene on Friday reported a spike in its year-over-year revenues and net loss.
 
The Rehovot, Israel-based agricultural genomics firm reported revenues of $870,000 for the three-month period ended Sept. 30, compared to $39,000 for the third quarter of 2007. The most recent quarter’s results include revenue from the firm’s recently signed collaboration with Monsanto.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: nasal microbial communities in asthma patients; sequencing-based way to detect, track schistosomiasis; and more.

The New York Times speaks with Vanderbilt's John Anthony Capra about Neanderthal genes in modern humans.

A draft guidance from the FDA suggests the agency wants to more tightly control gene-edited animals, according to Technology Review.

Researchers were among this weekend's protesters bemoaning the new US administration, Vox reports.